LRP5 and prostate carcinoma: Mechanistically, rtSPIRE1 stabilized LRP5 by inhibiting its ubiquitination and degradation, leading to sustained activation of the PI3K/AKT signaling pathway, which ultimately promotes prostate cancer cell proliferation and migration.